Antiarrhythmic Drugs Market Competitive Share & Forecast 2019: Pfizer, Novartis, Merck, Astra Zeneca
Antiarrhythmic drugs, also known as cardiac dysrhythmia medications, are a group of pharmaceuticals that are used to suppress abnormal rhythms of the heart (cardiac arrhythmias), such as atrial fibrillation, atrial flutter, ventricular tachycardia, and ventricular fibrillation.
View full press release